2026年3月最新《新锐期刊分区表》数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎反馈给我们。
![]() |
体验更多LetPub AI科研工具 >> | |
| 近期推荐: | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 新 聚合物期刊JPM征稿|IF持续上升 + APC折扣 | 热 Springer Nature特刊征稿 |
| |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | CTS-Clinical and Translational Science CTS-CLIN TRANSL SCI (此期刊被最新的JCR期刊SCIE收录) LetPub评分 6.2
51人评分
我要评分
声誉 7.1 影响力 5.0 速度 8.8 | |||||||||||||||||||||||||||||
| 期刊ISSN | 1752-8054 | 安装APP,查看期刊最新消息
| ||||||||||||||||||||||||||||
| E-ISSN | 1752-8062 | |||||||||||||||||||||||||||||
| 2024-2025最新影响因子 (数据来源于搜索引擎) | 2.8 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日:4.23 | |||||||||||||||||||||||||||||
| 2024-2025自引率 | 7.1%点击查看自引率趋势图 | |||||||||||||||||||||||||||||
| 五年影响因子 | 3.6 | |||||||||||||||||||||||||||||
| JCI期刊引文指标 | 0.74 | |||||||||||||||||||||||||||||
| h-index | 35 | |||||||||||||||||||||||||||||
| CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||
| 期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062 | |||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||
| 期刊投稿网址 | http://mc.manuscriptcentral.com/cts | |||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | QX008N, an Anti-TSLP Monoclonal Antibody: Pharmacokinetics, Tolerability, and Immunogenicity in Healthy Chinese Subjects Author: Shen, Zhen-Wei; Jiang, Qi; Wu, Kai-Qi; Jin, Ting-Han; Zhao, Jie; Guo, Tong; Fang, Min; Chen, Gui-Ling Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2026; Vol. 19, Issue 3, pp. -. DOI: 10.1111/cts.70473 Glucocorticoid-Induced Tumor Necrosis Factor Receptor Ligand: Correlation and Therapeutic Potential for Cognitive Impairment in Temporal Lobe Epilepsy Author: Li, Man; Shi, Jinying; Pan, Xiaodong; Huang, Huapin Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2026; Vol. 19, Issue 2, pp. -. DOI: 10.1111/cts.70477 Clinical Characteristics, Molecular Diagnosis, and Drug Resistance Profiles of Nontuberculous Mycobacteria Infections: A Retrospective Analysis Using PCR Melting Curve Technology Author: Wang, Kedi; Xu, Dongjiang; Gao, Yan; Zhao, Wen; Ma, Kaihui Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2026; Vol. 19, Issue 2, pp. -. DOI: 10.1111/cts.70479 Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of a Single-Dose JYB1904 in Healthy Chinese Participants: A Phase Ia, Randomized, Double-Blind, Placebo-Controlled Study Author: Shen, Zhen-Wei; Jin, Ting-Han; Wu, Kai-Qi; Zhao, Jie; Jiang, Qi; Guo, Tong; Li, Liang; Feng, Xiao-Hua; Liu, Pei-pei; Chen, Gui-Ling Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 6, pp. -. DOI: 10.1111/cts.70264 | |||||||||||||||||||||||||||||
| 期刊语言要求 | Language Manuscripts must be written in American English and be grammatically and linguistically correct. Authors should seek assistance with style, grammar and vocabulary if necessary. Your manuscript may also be sent back to you for revision if the quality of English language is poor. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CTS-Clinical and Translational Science的语言要求,还能让CTS-Clinical and Translational Science编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CTS-Clinical and Translational Science编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD3300; GBP4500; EUR3800; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:translational medicine、precision medicine、translational studies、quantitative pharmacology 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardPeer review | |||||||||||||||||||||||||||||
| 通讯方式 | WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148 | |||||||||||||||||||||||||||||
| 出版商 | Wiley-Blackwell Publishing Ltd | |||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-医学:研究与实验 | |||||||||||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||
| 出版周期 | Bimonthly | |||||||||||||||||||||||||||||
| 出版年份 | 2008 | |||||||||||||||||||||||||||||
| 年文章数 | 293点击查看年文章数趋势图 | |||||||||||||||||||||||||||||
| Gold OA文章占比 | 96.98% | |||||||||||||||||||||||||||||
| 研究类文章占比: 文章 ÷(文章 + 综述) | 85.67% | |||||||||||||||||||||||||||||
| WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:2区
| |||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版:不在预警名单中 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||
| 《新锐期刊分区表》 ( 2026年3月发布) | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||
| 期刊分区表 ( 2025年3月升级版) |
| |||||||||||||||||||||||||||||
| 期刊分区表 ( 2023年12月旧的升级版) |
| |||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1752-8054%5BISSN%5D | |||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验: 较慢,6-12周 | |||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; GBP4500; EUR3800; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在CTS-Clinical and Translational Science顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | QX008N, an Anti-TSLP Monoclonal Antibody: Pharmacokinetics, Tolerability, and Immunogenicity in Healthy Chinese Subjects Author: Shen, Zhen-Wei; Jiang, Qi; Wu, Kai-Qi; Jin, Ting-Han; Zhao, Jie; Guo, Tong; Fang, Min; Chen, Gui-Ling Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2026; Vol. 19, Issue 3, pp. -. DOI: 10.1111/cts.70473 PubMed DOI |
| 2. | Glucocorticoid-Induced Tumor Necrosis Factor Receptor Ligand: Correlation and Therapeutic Potential for Cognitive Impairment in Temporal Lobe Epilepsy Author: Li, Man; Shi, Jinying; Pan, Xiaodong; Huang, Huapin Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2026; Vol. 19, Issue 2, pp. -. DOI: 10.1111/cts.70477 PubMed DOI |
| 3. | Clinical Characteristics, Molecular Diagnosis, and Drug Resistance Profiles of Nontuberculous Mycobacteria Infections: A Retrospective Analysis Using PCR Melting Curve Technology Author: Wang, Kedi; Xu, Dongjiang; Gao, Yan; Zhao, Wen; Ma, Kaihui Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2026; Vol. 19, Issue 2, pp. -. DOI: 10.1111/cts.70479 PubMed DOI |
| 4. | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Profiles of a Single-Dose JYB1904 in Healthy Chinese Participants: A Phase Ia, Randomized, Double-Blind, Placebo-Controlled Study Author: Shen, Zhen-Wei; Jin, Ting-Han; Wu, Kai-Qi; Zhao, Jie; Jiang, Qi; Guo, Tong; Li, Liang; Feng, Xiao-Hua; Liu, Pei-pei; Chen, Gui-Ling Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 6, pp. -. DOI: 10.1111/cts.70264 PubMed DOI |
| 5. | Effect of Whole-Brain Radiotherapy Dose on the Occurrence of Otitis Media and Mastoiditis in Patients With Lung Cancer With Brain Metastasis Author: Zhang, Xudong; Huang, Ying; Li, Hongfei; Pei, Yuntong; Kong, Fanyang; Zhang, Qian; Song, Yadong; Wang, Yunji; Li, Guowen Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 6, pp. -. DOI: 10.1111/cts.70269 PubMed DOI |
| 6. | Clinical Pharmacology Overview of Tislelizumab in Patients With Advanced Tumors With a Focus on Racial Impact Author: Yu, Tian; Wu, Chi-Yuan; Sahasranaman, Srikumar; Tian, Xianbin; Fei Li, Ying; Tang, Zhiyu; Yang, Yanfei; Wan, Ya; Zhang, Quting; Schnell, Patrick; Mendoza-Naranjo, Ariadna; Abdrashitov, Ramil; Hanley, William D.; Budha, Nageshwar Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 5, pp. -. DOI: 10.1111/cts.70221 PubMed DOI |
| 7. | Alternative Dosing Regimens of Tislelizumab Using a Pharmacometrics Model-Based Approach Author: Rizwan, Ahsan; Giovinazzo, Hugh; Yu, Tian; Gao, Yuying; Wang, Kun; Xu, Fengyan; Wan, Ya; Wang, Jun; Sahasranaman, Srikumar; Campbell, Marcia; Schnell, Patrick; Abdrashitov, Ramil; Hanley, William D.; Budha, Nageshwar Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 5, pp. -. DOI: 10.1111/cts.70223 PubMed DOI |
| 8. | Bioequivalence and Food Effect Assessment of Two Fixed-Dose Combination Formulations of Telmisartan-Hydrochlorothiazide Tablets in Chinese Healthy Subjects Author: Hu, Minwan; Yang, Man; Zhang, Shuyu; Li, Jiangfan; Pang, Hongxian; Pei, Yingzi; Guo, Chao; Wang, Xuhong Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 5, pp. -. DOI: 10.1111/cts.70228 PubMed DOI |
| 9. | Ethnic Sensitivity Assessment of Mosunetuzumab Pharmacokinetics and Pharmacodynamics in Chinese Patients With Relapsed or Refractory Follicular Lymphoma Author: Li, Junyi; Liao, Michael Z.; Wilkins, Justin; Penuel, Elicia; Wang, Bei; Vadhavkar, Shweta; Peng, Kun; Cao, Junning; Li, Zhiming; Zhang, Ye; Li, Wenjin; Li, Donghang; Zhou, Mingzhu; Wei, Michael C.; Kwan, Antonia; Zhao, Rong; Li, Chunze; Li, Chi-Chung; Turner, David C Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 5, pp. -. DOI: 10.1111/cts.70211 PubMed DOI |
| 10. | Association of Vancomycin Plus Piperacillin-Tazobactam With Acute Kidney Injury: Differentiating Pseudo-Injury From True Nephrotoxicity Author: Chen, Congqin; Zhou, Rijing; Fang, Jie; Xiao, Jie Journal: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2025; Vol. 18, Issue 5, pp. -. DOI: 10.1111/cts.70258 PubMed DOI |
|
|
|
投稿状态统计: 我要评分: | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范?试试稿件自查工具,一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验:共24条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号:沪ICP备10217908号-1
沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室